Journey Medical Corp (DERM)
3.54
-0.04
(-1.12%)
USD |
NASDAQ |
May 10, 16:00
3.54
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Total Liabilities (Quarterly): 56.50M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 56.50M |
| September 30, 2023 | 48.54M |
| June 30, 2023 | 69.74M |
| March 31, 2023 | 88.36M |
| December 31, 2022 | 88.18M |
| September 30, 2022 | 81.96M |
| Date | Value |
|---|---|
| June 30, 2022 | 78.70M |
| March 31, 2022 | 79.46M |
| December 31, 2021 | 55.24M |
| September 30, 2021 | 100.77M |
| June 30, 2021 | 73.52M |
| December 31, 2020 | 41.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
41.61M
Minimum
Dec 2020
100.77M
Maximum
Sep 2021
71.88M
Average
76.11M
Median
Total Liabilities (Quarterly) Benchmarks
| Fortress Biotech Inc | 165.94M |
| GT Biopharma Inc | 6.633M |
| FibroGen Inc | 552.02M |
| Outlook Therapeutics Inc | 46.03M |
| ABVC BioPharma Inc | 6.362M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.85M |
| Shareholders Equity (Quarterly) | 20.35M |
| Debt to Equity Ratio | 0.7185 |
| Current Ratio | 1.348 |
| Net Debt Paydown Yield | 0.93% |